Sleep Disorders Trial, Recruiting NCT06999811 Sponsor: Medical University of South Carolina Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06999811
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are currently pregnant and between 13 weeks and 32 weeks and 6 days along in your pregnancy
  • You currently have, or have had in the past 3 years, an opioid use disorder (a dependence on or problematic use of opioids)
  • You have a prescription for a buprenorphine medication taken under the tongue (such as Suboxone, Subutex, or Zubsolv) to treat opioid use disorder
  • You live in the United States
  • You are between 18 and 45 years old

Who may not be able to join:

  • You are pregnant with more than one baby (such as twins or triplets)
  • You have certain high-risk pregnancy conditions, including severe nausea and vomiting, high blood pressure problems during pregnancy (such as preeclampsia), placenta previa, or vaginal bleeding after your first trimester
  • You are currently experiencing symptoms of psychosis or have active thoughts of suicide
  • You have a cognitive or emotional difficulty that would prevent you from fully understanding and agreeing to take part in the study (confirm with trial site)
  • You are currently incarcerated, expecting to be incarcerated, or living in an institution during the time the study takes place
  • You do not speak English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sara Witcraft, Medical University of South Carolina

Phone: 843-998-4211

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 November 2025
Est. completion
15 October 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of Recruitment; Retention in Active Treatment (EMPWR); Engagement in intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov